S&S Insider reported that the U.S. central venous catheter market is projected to hit USD 1.09 billion by 2032 as demand for oncology, dialysis, and ICU procedures accelerates.Austin, Sept. 30, 2025 ...
Each year, more than 2.2 million children around the world undergo central venous access procedures, with a thin, flexible ...
The family of a Lufkin man has filed a wrongful-death lawsuit against Woodland Heights Medical Center, alleging a nurse’s ...
Central venous access devices (CVADs) are thin, flexible tubes inserted into large veins to deliver essential medications and fluids directly into the ...
The vascular access device market is experiencing a steady growth rate with a CAGR of ~6% during the forecast period. The ...
Replying to submission by V.D. Satheesan, Veena George says top-level panel of government doctors is exploring whether ‘guide ...
(MENAFN- GlobeNewsWire - Nasdaq) ST. LOUIS, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular ...
ST. LOUIS, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the ...
FORT MILL, S.C., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company and leader in innovative cardiac electrophysiology solutions, is ...
Fort Mill, S.C., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback